Enveric Biosciences (STU:SLZ0) EPS (Basic): €-23.49 (TTM As of Mar. 2026)


STU:SLZ0 Enveric Biosciences Inc STU:SLZ0
26 GF Score
Price €55.89
! 1 Warning Sign
View Full Analysis

What is Enveric Biosciences EPS (Basic)?

Enveric Biosciences STU:SLZ0 26 EPS (Basic) is €-23.49 as of Mar. 2026. GuruFocus rates STU:SLZ0 with a GF Score™ of 26/100. The stock has 1 warning sign investors should review.

Enveric Biosciences's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was €-0.93. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was €-23.49.

Enveric Biosciences's EPS (Diluted) for the three months ended in Mar. 2026 was €-0.93. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €-23.49.

Enveric Biosciences's EPS without NRI for the three months ended in Mar. 2026 was €-0.93. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -23.49.

During the past 3 years, the average EPS without NRI Growth Rate was 75.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 65.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 57.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Enveric Biosciences's highest 3-Year average EPS without NRI Growth Rate was 77.80% per year. The lowest was -87.80% per year. And the median was 69.90% per year.

Enveric Biosciences  (STU:SLZ0) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Enveric Biosciences EPS (Basic) Related Terms

Enveric Biosciences EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Enveric Biosciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enveric Biosciences EPS (Basic) Chart

Enveric Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16,517.82 -2,208.96 -1,334.68 -218.20 -30.95

Enveric Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.49 -10.09 -9.21 -3.25 -0.93
STU:SLZ0
26GF Score
Enveric Biosciences Inc STU:SLZ0
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enveric Biosciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Enveric Biosciences's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-7.491-0)/0.335
=-22.36

Enveric Biosciences's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.413-0)/1.510
=-0.94

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-23.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €-23.49 mean?
Enveric Biosciences (STU:SLZ0) has a EPS (Basic) of €-23.49 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Enveric Biosciences and its competitors.
Is Enveric Biosciences' EPS (Basic) too high?
Enveric Biosciences' current EPS (Basic) is €-23.49. Overall, Enveric Biosciences has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Enveric Biosciences' EPS (Basic) compare to ACXP and CELZ?
Enveric Biosciences' EPS (Basic) of €-23.49 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Enveric Biosciences and its competitors. Enveric Biosciences's current EPS (Basic) is €-23.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enveric Biosciences stock overvalued right now?
Enveric Biosciences (STU:SLZ0) has a current EPS (Basic) of €-23.49. The current EPS (Basic) is €-23.49. Enveric Biosciences' overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Enveric Biosciences (STU:SLZ0), the current EPS (Basic) is €-23.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enveric Biosciences Business Description

Other Exchanges ENVB:USA
Address 245 First Street, 18th Floor, Riverview II, Cambridge, MA, USA, 02142
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
26GF Score

Get the complete analysis for STU:SLZ0

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€55.89
Price